Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WEBER, Michael J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 9 of 9

  • Page / 1
Export

Selection :

  • and

Tumor necrosis factor a induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cellsKULIK, George; CARSON, Jonathan P; VOMASTEK, Tomas et al.Cancer research (Baltimore). 2001, Vol 61, Num 6, pp 2713-2719, issn 0008-5472Article

The Neuroendocrine-Derived Peptide Parathyroid Hormone-Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen ReceptorDASILVA, John; GIOELI, Daniel; WEBER, Michael J et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 18, pp 7402-7411, issn 0008-5472, 10 p.Article

The Current State of Preclinical Prostate Cancer Animal ModelsPIENTA, Kenneth J; ABATE-SHEN, Cory; SIMONS, Jonathon W et al.The Prostate. 2008, Vol 68, Num 6, pp 629-639, issn 0270-4137, 11 p.Article

Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4-2 prostate cancer cellsBAKIN, Robert E; GIOELI, Daniel; BISSONETTE, Eric A et al.Cancer research (Baltimore). 2003, Vol 63, Num 8, pp 1975-1980, issn 0008-5472, 6 p.Article

Constitutive activation of the ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cellsBAKIN, Robert E; GIOELI, Daniel; SIKES, Robert A et al.Cancer research (Baltimore). 2003, Vol 63, Num 8, pp 1981-1989, issn 0008-5472, 9 p.Article

Rap2 regulates androgen sensitivity in human prostate cancer cellsBIGLER, Dora; GIOELI, Daniel; CONAWAY, Mark R et al.The Prostate. 2007, Vol 67, Num 14, pp 1590-1599, issn 0270-4137, 10 p.Article

Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cellsCARSON, Jonathan P; BEHNAM, Marcelina; SUTTON, Jennifer N et al.Cancer research (Baltimore). 2002, Vol 62, Num 1, pp 18-23, issn 0008-5472Article

Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)SLINGLUFF, Craig L; PETRONI, Gina R; GROSH, William W et al.Clinical cancer research (Print). 2013, Vol 19, Num 13, pp 3611-3620, issn 1078-0432, 10 p.Article

Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptorKRAUS, Sarah; GIOELI, Daniel; VOMASTEK, Tomas et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 11047-11054, issn 0008-5472, 8 p.Article

  • Page / 1